TLOG (TetraLogic Pharmaceuticals) Total Operating Expense: $23.62 Mil (TTM As of Sep. 2016)


What is TetraLogic Pharmaceuticals Total Operating Expense?

TetraLogic Pharmaceuticals TLOG Total Operating Expense is $23.62 Mil as of Sep. 2016.

TetraLogic Pharmaceuticals's Total Operating Expense for the three months ended in Sep. 2016 was $3.76 Mil. TetraLogic Pharmaceuticals's Total Operating Expense for the trailing twelve months (TTM) ended in Sep. 2016 was $23.62 Mil.

TetraLogic Pharmaceuticals Total Operating Expense Related Terms

TetraLogic Pharmaceuticals Total Operating Expense Historical Data

* Premium members only.

The historical data trend for TetraLogic Pharmaceuticals's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TetraLogic Pharmaceuticals Total Operating Expense Chart

TetraLogic Pharmaceuticals Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15
Total Operating Expense
18.87 16.17 17.99 31.21 38.50

TetraLogic Pharmaceuticals Quarterly Data
Dec11 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.62 9.71 6.27 3.88 3.76

TetraLogic Pharmaceuticals Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Sep. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $23.62 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $23.62 Mil mean?
TetraLogic Pharmaceuticals (TLOG) has a Total Operating Expense of $23.62 Mil as of Sep. 2016. Total operating expense is the primary recurring expense associated with central operations. View historical data on TetraLogic Pharmaceuticals and its competitors.
Is TetraLogic Pharmaceuticals' Total Operating Expense too high?
TetraLogic Pharmaceuticals' current Total Operating Expense is $23.62 Mil.
How does TetraLogic Pharmaceuticals' Total Operating Expense compare to ARGSQ and GTHR?
TetraLogic Pharmaceuticals' Total Operating Expense of $23.62 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on TetraLogic Pharmaceuticals and its competitors. TetraLogic Pharmaceuticals's current Total Operating Expense is $23.62 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TetraLogic Pharmaceuticals stock overvalued right now?
TetraLogic Pharmaceuticals (TLOG) has a current Total Operating Expense of $23.62 Mil. The current Total Operating Expense is $23.62 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For TetraLogic Pharmaceuticals (TLOG), the current Total Operating Expense is $23.62 Mil as of Sep. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TetraLogic Pharmaceuticals Business Description

Address 343 Phoenixville Pike, Malvern, PA, USA, 19355
TetraLogic Pharmaceuticals Corp is a biopharmaceutical company. The company is engaged in developing novel small molecule therapeutics in oncology.